Laddar...
Immune checkpoint therapy in liver cancer
Immune checkpoints include stimulatory and inhibitory checkpoint molecules. In recent years, inhibitory checkpoints, including cytotoxic T lymphocyte–associated antigen 4 (CTLA-4), programmed cell death protein-1 (PD-1), and programmed cell death ligand 1 (PD-L1), have been identified to suppress an...
Sparad:
| I publikationen: | J Exp Clin Cancer Res |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5975687/ https://ncbi.nlm.nih.gov/pubmed/29843754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-018-0777-4 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|